Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › JAK1 pathway inhibitors for the treatment of gastrointestinal disease

JAK1 pathway inhibitors for the treatment of gastrointestinal disease

US Patent 12150943 · Granted Nov 26, 2024

Estimated economic value: $37,065,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of hidradenitis suppurativa using JAK inhibitors2025
JAK1 pathway inhibitors for the treatment of prurigo nodularis2025
Dosing regimen for the treatment of PI3K related disorders2025
Topical formulation for a JAK inhibitor2025
Sustained release dosage forms for a JAK1 inhibitor2024
JAK inhibitor with a vitamin D analog for treatment of skin diseases2024
Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Li2024
JAK1 pathway inhibitors for the treatment of vitiligo2024
Combination therapy comprising JAK pathway inhibitor and rock inhibitor2024
Sustained-release dosage forms of ruxolitinib2024
Methods of treating cancer with an FGFR inhibitor2023
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2023